Immuneering Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +172.5% | +333.9% | -26.6% | -16.2% | -48.6% | +340.1% | |
| – | +168.3% | +303.7% | -28.6% | -18.1% | -55.6% | +345.2% | |
| – | +169.1% | +101.9% | -3.0% | -18.2% | -39.2% | +255.9% | |
| – | +169.1% | +302.3% | -29.3% | -18.8% | -57.8% | +378.2% | |
| – | +138.2% | -50.8% | -95.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | |
| – | +1,820.5% | +19.2% | +69.7% | – | – | – | |
| – | – | – | -0.2% | +0.0% | +0.0% | +0.0% | |
| – | – | – | -6.8% | -7.2% | -7.7% | -8.4% | |
| – | +195.3% | -82.4% | +16.7% | -4.1% | -5.7% | +19.2% | |
| – | +346.4% | +149.7% | +43.0% | -2.6% | -4.4% | +34.2% | |
| – | – | +259.1% | +38.2% | -20.8% | +12.8% | +17.3% | |
| – | +402.0% | -5.8% | +126.2% | -33.1% | -7.3% | -21.2% | |
| – | – | – | -29.6% | -17.5% | -54.3% | +427.9% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +94.8% | +0.3% | +7.7% | +5.5% | +46.8% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.